Skip to Content
AHIP
Issues

High-Price Drugs

Our Position

Everyone should be able to get the medications they need at a cost they can afford. But drug prices are out of control, and hardworking families feel the consequences every day. It’s time to hold pharmaceutical companies accountable for the prices that they, and they alone, set and increase year after year.

Health insurance providers fight against high prices for more affordable medications for Americans. We do not have to choose between innovation and affordability. With the right solutions, Americans can have both.

Go to

Resources

View More

News

Fact Check: Manufacturers Set High Drug Prices and Prevent Competition

Sticker Shock: New Research Shows an Average List Price Increase of Over 200% for Top Part D Drugs

Research released by AARP’s Public Policy Institute (PPI), list prices for the top 25 Medicare Part D drugs have increased by an average of 226%.

Getting the Facts: Drug Companies Increasingly Using Patent Games to Avoid Competition

A recent article published by STAT highlights how Big Pharma is using continuation patents to keep lower-cost generic drugs from reaching the market.

View More News

AHIP State Contacts

Find contact information for AHIP state affairs staff and view state-specific resources.

View States